Iteos Therapeutics Inc
NASDAQ:ITOS

Watchlist Manager
Iteos Therapeutics Inc Logo
Iteos Therapeutics Inc
NASDAQ:ITOS
Watchlist
Price: 8.34 USD -5.55% Market Closed
Market Cap: 304.6m USD
Have any thoughts about
Iteos Therapeutics Inc?
Write Note

Iteos Therapeutics Inc
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Iteos Therapeutics Inc
Selling, General & Administrative Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Iteos Therapeutics Inc
NASDAQ:ITOS
Selling, General & Administrative
-$50.4m
CAGR 3-Years
-49%
CAGR 5-Years
-64%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Selling, General & Administrative
-$14B
CAGR 3-Years
-5%
CAGR 5-Years
-15%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Selling, General & Administrative
-$5.6B
CAGR 3-Years
-2%
CAGR 5-Years
-6%
CAGR 10-Years
-8%
Amgen Inc
NASDAQ:AMGN
Selling, General & Administrative
-$7.5B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Selling, General & Administrative
-$1.5B
CAGR 3-Years
-22%
CAGR 5-Years
-19%
CAGR 10-Years
-17%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Selling, General & Administrative
-$2.9B
CAGR 3-Years
-23%
CAGR 5-Years
-16%
CAGR 10-Years
-21%

See Also

What is Iteos Therapeutics Inc's Selling, General & Administrative?
Selling, General & Administrative
-50.4m USD

Based on the financial report for Dec 31, 2023, Iteos Therapeutics Inc's Selling, General & Administrative amounts to -50.4m USD.

What is Iteos Therapeutics Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-64%

Over the last year, the Selling, General & Administrative growth was -15%. The average annual Selling, General & Administrative growth rates for Iteos Therapeutics Inc have been -49% over the past three years , -64% over the past five years .

Back to Top